PURPOSE: To inform development of a culturally sensitive hereditary breast and ovarian cancer communication initiative and related clinical genetic services. METHODS: Five focus groups were conducted with 51 female and male Latinos. Educational materials were designed to communicate information about hereditary breast or ovarian cancer and availability of relevant clinical services or prevention strategies. Focus groups explored participants' knowledge, attitudes, and beliefs about hereditary breast and ovarian cancer, BRCA1/2 testing, and communication preferences for hereditary breast and ovarian cancer health messages. RESULTS: Overall, awareness of familial breast and ovarian cancer and availability of genetic risk assessment was low. Once informed, participants held favorable attitudes toward risk assessment and counseling services. Critical themes of the research highlighted the need to provide bilingual media products and use of a variety of strategies to increase awareness about hereditary cancer risk and availability of clinical genetic services. Important barriers were identified regarding family cancer history communication and cancer prevention services. Strategies were suggested for communicating cancer genetic information to increase awareness and overcome these barriers; these included both targeted and tailored approaches. CONCLUSION: This research suggests that cancer genetic communication efforts should consider community and cultural perspectives as well as health care access issues before widespread implementation.
PURPOSE: To inform development of a culturally sensitive hereditary breast and ovarian cancer communication initiative and related clinical genetic services. METHODS: Five focus groups were conducted with 51 female and male Latinos. Educational materials were designed to communicate information about hereditary breast or ovarian cancer and availability of relevant clinical services or prevention strategies. Focus groups explored participants' knowledge, attitudes, and beliefs about hereditary breast and ovarian cancer, BRCA1/2 testing, and communication preferences for hereditary breast and ovarian cancer health messages. RESULTS: Overall, awareness of familial breast and ovarian cancer and availability of genetic risk assessment was low. Once informed, participants held favorable attitudes toward risk assessment and counseling services. Critical themes of the research highlighted the need to provide bilingual media products and use of a variety of strategies to increase awareness about hereditary cancer risk and availability of clinical genetic services. Important barriers were identified regarding family cancer history communication and cancer prevention services. Strategies were suggested for communicating cancer genetic information to increase awareness and overcome these barriers; these included both targeted and tailored approaches. CONCLUSION: This research suggests that cancer genetic communication efforts should consider community and cultural perspectives as well as health care access issues before widespread implementation.
Authors: Anita Yeomans Kinney; Sara Ellis Simonsen; Bonnie Jeanne Baty; Diptasri Mandal; Susan L Neuhausen; Kate Seggar; Rich Holubkov; Ken Smith Journal: Am J Med Genet A Date: 2006-04-15 Impact factor: 2.802
Authors: Jennifer N Eichmeyer; Hope Northrup; Michael A Assel; Thomas J Goka; Dennis A Johnston; Aimee Tucker Williams Journal: J Genet Couns Date: 2005-08 Impact factor: 2.537
Authors: Gordon F Schwartz; Kevin S Hughes; Henry T Lynch; Carol J Fabian; Ian S Fentiman; Mark E Robson; Susan M Domchek; Lynn C Hartmann; Roland Holland; David J Winchester Journal: Cancer Date: 2008-11-15 Impact factor: 6.860
Authors: Suzanne Mellon; James Janisse; Robin Gold; Michelle Cichon; Lisa Berry-Bobovski; Michael A Tainsky; Michael S Simon Journal: Health Psychol Date: 2009-01 Impact factor: 4.267
Authors: Olufunmilayo I Olopade; James D Fackenthal; Georgia Dunston; Michael A Tainsky; Francis Collins; Carolyn Whitfield-Broome Journal: Cancer Date: 2003-01-01 Impact factor: 6.860
Authors: Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters Journal: Contemp Clin Trials Date: 2018-09-18 Impact factor: 2.226
Authors: Alejandra Hurtado-de-Mendoza; Kristi D Graves; Sara Gómez-Trillos; Minna Song; Lyndsay Anderson; Claudia Campos; Pilar Carrera; Nancy Ostrove; Beth N Peshkin; Marc D Schwartz; Nan Ficca; Ana-Paula Cupertino; Nathaly Gonzalez; Andrea Otero; Elmer Huerta; Vanessa B Sheppard Journal: J Community Genet Date: 2019-05-18
Authors: Esther M John; Alison J Canchola; Meera Sangaramoorthy; Jocelyn Koo; Alice S Whittemore; Dee W West Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254